HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li-Ping Wang Selected Research

EPOCH protocol

4/2014[Long-term follow-up for 39 newly diagnosed diffused large B-cell lymphoma patients treated by (R)-EPOCH].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li-Ping Wang Research Topics

Disease

30Neoplasms (Cancer)
03/2022 - 03/2005
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2014
7Lung Neoplasms (Lung Cancer)
01/2021 - 10/2006
6Ischemic Stroke
04/2022 - 04/2016
6Inflammation (Inflammations)
09/2021 - 05/2011
6Insulin Resistance
01/2021 - 03/2003
6Neoplasm Metastasis (Metastasis)
01/2021 - 03/2012
6Breast Neoplasms (Breast Cancer)
07/2020 - 02/2008
5Infections
03/2022 - 01/2015
5Pain (Aches)
09/2021 - 08/2011
5Prostatic Neoplasms (Prostate Cancer)
01/2020 - 09/2013
5Brain Ischemia (Cerebral Ischemia)
01/2019 - 12/2005
5Stroke (Strokes)
01/2019 - 05/2014
5Fibrosis (Cirrhosis)
01/2019 - 03/2014
5Obesity
11/2017 - 03/2007
4Necrosis
10/2018 - 01/2014
4Hypertension (High Blood Pressure)
01/2017 - 01/2013
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022 - 04/2016
3Wounds and Injuries (Trauma)
04/2021 - 02/2009
3Body Weight (Weight, Body)
01/2020 - 02/2012
3Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 01/2017
3Hepatitis B
11/2018 - 01/2017
3Hyperplasia
01/2018 - 07/2014
3Pneumonia (Pneumonitis)
11/2017 - 01/2014
3Hyperglycemia
01/2016 - 07/2005
3Infarction (Infarctions)
01/2015 - 01/2013
3Cicatrix (Scar)
01/2015 - 12/2005
3Colorectal Neoplasms (Colorectal Cancer)
06/2014 - 07/2013
3Cardiomyopathies (Cardiomyopathy)
05/2014 - 03/2013
3Myocardial Infarction
05/2014 - 01/2013
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2013 - 06/2007
2Atrophy
01/2022 - 01/2020
2Liver Neoplasms (Liver Cancer)
01/2020 - 05/2018
2Brain Injuries (Brain Injury)
01/2020 - 01/2019
2Ischemia
01/2018 - 07/2005
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2017 - 04/2014
2Residual Neoplasm
10/2016 - 06/2011
2Ovarian Neoplasms (Ovarian Cancer)
10/2016 - 09/2014
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2016 - 07/2005
2Stomach Neoplasms (Stomach Cancer)
01/2016 - 11/2013
2Hypertrophy
01/2016 - 11/2015
2Liver Cirrhosis (Hepatic Cirrhosis)
04/2015 - 01/2014
2Hemorrhagic Fever with Renal Syndrome (HFRS)
01/2015 - 01/2011
2Lung Injury
03/2014 - 01/2014
2Carcinoma (Carcinomatosis)
06/2012 - 06/2011
2Migraine Disorders (Migraine)
05/2012 - 08/2011

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
12/2019 - 01/2011
6Biomarkers (Surrogate Marker)IBA
07/2020 - 03/2012
6CytokinesIBA
07/2014 - 05/2011
5Pharmaceutical PreparationsIBA
04/2022 - 04/2012
5CollagenIBA
11/2016 - 01/2014
5Messenger RNA (mRNA)IBA
01/2014 - 06/2012
4ErbB Receptors (EGF Receptor)IBA
10/2020 - 01/2014
4EnzymesIBA
11/2013 - 10/2006
4salicylhydroxamic acid (SHAM)IBA
03/2013 - 08/2011
3Long Noncoding RNAIBA
03/2022 - 09/2014
3Pemetrexed (MTA)FDA Link
10/2020 - 04/2013
3MicroRNAs (MicroRNA)IBA
01/2019 - 05/2012
3Hepatitis B Surface Antigens (HBsAg)FDA Link
11/2018 - 01/2017
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 06/2012
3RNA (Ribonucleic Acid)IBA
12/2016 - 05/2012
3Streptozocin (Streptozotocin)FDA Link
04/2016 - 07/2005
3Heat-Shock Proteins (Heat-Shock Protein)IBA
07/2014 - 07/2005
3ImmunosorbentsIBA
11/2013 - 10/2006
3LipidsIBA
05/2011 - 03/2003
2CateninsIBA
01/2022 - 07/2013
2Analgesics (Analgesic Drugs)IBA
09/2021 - 07/2015
2AntigensIBA
01/2021 - 03/2012
2Tyrosine Kinase InhibitorsIBA
01/2021 - 09/2020
2icotinibIBA
02/2020 - 01/2020
2Indicators and Reagents (Reagents)IBA
01/2020 - 08/2012
2Interleukin-6 (Interleukin 6)IBA
01/2020 - 03/2014
2Interleukin-10 (Interleukin 10)IBA
01/2020 - 06/2014
2Caspase 3 (Caspase-3)IBA
12/2019 - 12/2017
2Methotrexate (Mexate)FDA LinkGeneric
08/2019 - 10/2016
2Anti-Bacterial Agents (Antibiotics)IBA
06/2019 - 04/2016
2Alanine Transaminase (SGPT)IBA
01/2019 - 03/2012
2AntibodiesIBA
03/2018 - 03/2014
2erucylphosphocholineIBA
01/2018 - 01/2018
2Imatinib Mesylate (Gleevec)FDA Link
11/2017 - 04/2017
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2017 - 12/2016
2TRAM 34IBA
11/2016 - 11/2015
2AngiotensinsIBA
11/2016 - 11/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 04/2010
2Peptides (Polypeptides)IBA
07/2014 - 01/2014
2ChemokinesIBA
06/2014 - 07/2011
2LigandsIBA
06/2014 - 07/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2014 - 10/2006
2Interleukin-17 (Interleukin 17)IBA
03/2014 - 01/2014
2Trefoil FactorsIBA
11/2013 - 07/2013
2Fatty Acids (Saturated Fatty Acids)IBA
05/2011 - 03/2007
2CeramidesIBA
05/2011 - 03/2007
2Nonesterified Fatty Acids (NEFA)IBA
04/2010 - 06/2007
2NestinIBA
12/2005 - 03/2005

Therapy/Procedure

13Therapeutics
04/2022 - 11/2005
11Drug Therapy (Chemotherapy)
10/2020 - 04/2010
4Transplantation
01/2022 - 05/2014
4Aftercare (After-Treatment)
01/2021 - 07/2018
2Intraperitoneal Injections
01/2020 - 01/2014
2Prostatectomy (Retropubic Prostatectomy)
04/2018 - 01/2016